These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 7911844
1. Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines. Tsai CM, Perng RP, Chen MH, Jan YH, Hung MC, Ku TY, Chang KT. J Natl Cancer Inst; 1994 Jul 06; 86(13):1018-20. PubMed ID: 7911844 [No Abstract] [Full Text] [Related]
2. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis. Hilbe W, Dirnhofer S, Oberwasserlechner F, Eisterer W, Ammann K, Schmid T, Hilbe G, Thaler J, Wöll E. J Clin Pathol; 2003 Oct 06; 56(10):736-41. PubMed ID: 14514775 [Abstract] [Full Text] [Related]
3. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA, Kern JA. Cancer Res; 1990 Jan 15; 50(2):421-5. PubMed ID: 1967224 [Abstract] [Full Text] [Related]
7. Quantification of erbB-2/neu levels in tissue. Paik S, King CR, Simpson S, Lippman ME. Methods Enzymol; 1991 Jul 20; 198():290-300. PubMed ID: 1677445 [No Abstract] [Full Text] [Related]
8. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. Kashihara M, Azuma K, Kawahara A, Basaki Y, Hattori S, Yanagawa T, Terazaki Y, Takamori S, Shirouzu K, Aizawa H, Nakano K, Kage M, Kuwano M, Ono M. J Thorac Oncol; 2009 Sep 20; 4(9):1066-74. PubMed ID: 19648825 [Abstract] [Full Text] [Related]
9. SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer. Azuma Y, Yokobori T, Mogi A, Altan B, Yajima T, Kosaka T, Onozato R, Yamaki E, Asao T, Nishiyama M, Kuwano H. J Surg Oncol; 2015 Aug 20; 112(2):231-7. PubMed ID: 26180037 [Abstract] [Full Text] [Related]
10. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL, Hung MC. Cancer Res; 1994 Jun 15; 54(12):3260-6. PubMed ID: 7911396 [Abstract] [Full Text] [Related]
11. Expression of C-erb B2 in tumours and tumour-like lesions of the thyroid. Soares P, Sambade C, Sobrinho-Simões M. Int J Cancer; 1994 Feb 01; 56(3):459-61. PubMed ID: 7906256 [No Abstract] [Full Text] [Related]
19. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay. Watanabe T, Fukutomi T, Tsuda H, Adachi I, Nanasawa T, Yamamoto H, Abe K. Jpn J Cancer Res; 1993 Dec 15; 84(12):1279-86. PubMed ID: 7904987 [Abstract] [Full Text] [Related]
20. Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. Dittadi R, Gion M, Pagan V, Brazzale A, Del Maschio O, Bargossi A, Busetto A, Bruscagnin G. Br J Cancer; 1991 Oct 15; 64(4):741-4. PubMed ID: 1654986 [Abstract] [Full Text] [Related] Page: [Next] [New Search]